WASHINGTON: Nasdaq has withdrawn a decision to delist the shares of Luokung Technology Corp, the Chinese mapping technology company said on Thursday , after a US judge suspended an imminent investment ban imposed under the Trump administration.
Luokung is the second company on a US list of alleged Communist Chinese military companies subject to an investment ban to win a preliminary injunction halting the designation.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
South Korea's Kakao to buy 2 US storytelling apps for US$950 millionSEOUL: South Korea's Kakao Entertainment said on Tuesday (May 11) it was acquiring US-based online comic app Tapas and serialised fiction app ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
South Pole, Mitsubishi eye up to US$800 million of carbon removal credits by 2030LONDON: Swiss company South Pole is developing a carbon removal purchase facility with Japan's Mitsubishi Corp which aims to procure US$300 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US embassy in Beijing apologises for comparing Chinese students to playful puppiesThis analogy literally reminded the Chinese of the worst times of Western imperialism in China, when a 'Chinese and dogs not permitted' sign hung at the entrance of a French colony in Shanghai. As an embassy, they really need to have some cultural sensitivity.
Source: TODAYonline - 🏆 1. / 99 Read more »
US sends more reinforcements for Afghan pullout: PentagonThe US military has deployed more heavy bombers and fighter jets to protect withdrawing American and coalition troops from Afghanistan, which have ... This is an extremely risky operation. Loser. The mightiest army in the world can't defeat the Taliban forces. Lousy. Taliban 1 USA 0
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer sees robust COVID-19 vaccine demand for years, US$26 billion in 2021 salesPfizer on Tuesday (May 4) raised its forecast for 2021 COVID-19 vaccine sales by more than 70 per cent to US$26 billion and said demand from ... 輝瑞疫苗賺大錢了！
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »